Samantha Howe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Samantha Howe has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Tony Blakely
Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
10 shared publications - Tim Wilson
University of Melbourne
8 shared publications - Driss Ait Ouakrim
Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia
7 shared publications - Coral Gartner
School of Public Health, The University of Queensland Faculty of Medicine, Herston, Queensland, Australia
6 shared publications Driss Ait Ouakrim
Melbourne School of Population and Global Health, University of Melbourne
3 shared publicationsTim Wilson
Melbourne School of Population and Global Health, University of Melbourne
3 shared publications
Latest Publications
- 25 October 2026
- Published by BMJ in Tobacco Control
Modelling the impacts of illicit tobacco and e-cigarette market enforcement: Australian case study
Background In Australia, daily smoking prevalence has fallen below 10% as of 2022–2023. However, prevalence of recent illicit tobacco use has increased, from 1.6% in 2019 to 3.8% in 2025. Recent policy changes have restricted e-cigarette sales to pharmacies, yet illicit supply remains widespread. We aimed to estimate how increasing enforcement against illicit tobacco and e-cigarettes might affect future smoking, vaping and mortality. Methods We used the SHINE-Tobacco simulation model that combines a Markov model of yearly smoking, vaping and dual use transitions, with a proportional multistate lifetable of tobacco-related diseases. We compare a ‘business-as-usual’ (BAU) scenario in which overall smoking declines (based on 2001–2022/2023 trends), but illicitly traded tobacco and e-cigarettes remain widespread, to four hypothetical enforcement scenarios starting in 2025 that vary by intensity (maximum 90% reduction) and whether increased pharmacy e-cigarette use occurs. Findings Under BAU, daily smoking prevalence declined from 9.1% in 2024 to 6.1% in 2044, while vaping increased from 4.8% to 9.9%. High illicit market enforcement reduced smoking to 4.5% and vaping to 1.3% by 2044. The largest reduction in smoking occurred under high illicit enforcement alongside ongoing e-cigarette use (via pharmacies) for smoking cessation, reducing smoking to 3.0% and averting 8370 deaths over 20 years (95% uncertainty interval 6970–10 100). While the model was moderately sensitive to changes in BAU assumptions, enforcement scenario rankings remained the same across sensitivity analyses. Conclusions Future smoking trajectories in Australia are likely to depend on both illicit product availability and the role of e-cigarettes in cessation. Future research is required to determine how hypothetical enforcement impacts could be achieved.
- 25 October 2026
- Published by BMJ in Tobacco Control
Modelling the impacts of illicit tobacco and e-cigarette market enforcement: Australian case study
Background In Australia, daily smoking prevalence has fallen below 10% as of 2022–2023. However, prevalence of recent illicit tobacco use has increased, from 1.6% in 2019 to 3.8% in 2025. Recent policy changes have restricted e-cigarette sales to pharmacies, yet illicit supply remains widespread. We aimed to estimate how increasing enforcement against illicit tobacco and e-cigarettes might affect future smoking, vaping and mortality. Methods We used the SHINE-Tobacco simulation model that combines a Markov model of yearly smoking, vaping and dual use transitions, with a proportional multistate lifetable of tobacco-related diseases. We compare a ‘business-as-usual’ (BAU) scenario in which overall smoking declines (based on 2001–2022/2023 trends), but illicitly traded tobacco and e-cigarettes remain widespread, to four hypothetical enforcement scenarios starting in 2025 that vary by intensity (maximum 90% reduction) and whether increased pharmacy e-cigarette use occurs. Findings Under BAU, daily smoking prevalence declined from 9.1% in 2024 to 6.1% in 2044, while vaping increased from 4.8% to 9.9%. High illicit market enforcement reduced smoking to 4.5% and vaping to 1.3% by 2044. The largest reduction in smoking occurred under high illicit enforcement alongside ongoing e-cigarette use (via pharmacies) for smoking cessation, reducing smoking to 3.0% and averting 8370 deaths over 20 years (95% uncertainty interval 6970–10 100). While the model was moderately sensitive to changes in BAU assumptions, enforcement scenario rankings remained the same across sensitivity analyses. Conclusions Future smoking trajectories in Australia are likely to depend on both illicit product availability and the role of e-cigarettes in cessation. Future research is required to determine how hypothetical enforcement impacts could be achieved.
- Open Access
Estimating the impact of a denicotinisation policy on smoking behaviours in Australia – an expert knowledge elicitation study
Background: Mandatory reductions in tobacco product nicotine content to non-addictive levels may help achieve a tobacco endgame. Evidence exists for potential positive impacts of ‘very low nicotine content’ (VLNC) cigarettes in promoting smoking cessation in trial settings, but the population-level policy impact is unknown. Methods: An online expert knowledge elicitation survey was undertaken to generate estimates for the impact of a VLNC mandate in Australia. Global experts in tobacco control were recruited to individually estimate impacts on smoking initiation, cessation, and switching to e-cigarettes or illicit market cigarettes. Linear pooling was used to estimate a combined (non-parametric) distribution per question, incorporating minimum, maximum, and best guess values from each respondent. Results: The survey was completed by 15 experts. Interquartile ranges from pooled responses indicated that in the first year of a VLNC policy, smoking cessation could increase by 1.2-7.1 times the rate without the policy and switching to vaping by 1.3-8 times. Switching to illicitly supplied ‘normal’ nicotine cigarettes was estimated between 15-50% of those who smoke. Smoking initiation estimates varied greatly. Experts from Australia (n=8) consistently reported lower estimates for positive outcomes, and higher illicit market switching estimates, than experts from other countries. Conclusions: Given the absence of implementation evidence, this study provides Australia-specific estimates of the potential behavioural effects of a VLNC policy. The findings suggest that denicotinisation would accelerate declines in smoking, but that it may be undermined by illicit cigarette access in Australia. Estimates should be updated with real-world evidence as it becomes available. Implications: This study quantifies a range of behavioural responses to a national-level VLNC mandate in Australia, based on the knowledge of 15 global experts in tobacco control. The pooled responses indicate that a VLNC mandate could increase smoking cessation and switching to e-cigarette use, with variable impacts on youth smoking and vaping uptake. Denicotinisation could accelerate progress towards a tobacco endgame in Australia, but its benefits may be limited if illicit access to nicotine-containing cigarettes continues. Future modelling in Australia based on this analysis must explicitly consider the wide variation in expert responses, and other sources of evidence.
Open AccessEstimating the impact of a denicotinisation policy on smoking behaviours in Australia – an expert knowledge elicitation study
Background: Mandatory reductions in tobacco product nicotine content to non-addictive levels may help achieve a tobacco endgame. Evidence exists for potential positive impacts of ‘very low nicotine content’ (VLNC) cigarettes in promoting smoking cessation in trial settings, but the population-level policy impact is unknown. Methods: An online expert knowledge elicitation survey was undertaken to generate estimates for the impact of a VLNC mandate in Australia. Global experts in tobacco control were recruited to individually estimate impacts on smoking initiation, cessation, and switching to e-cigarettes or illicit market cigarettes. Linear pooling was used to estimate a combined (non-parametric) distribution per question, incorporating minimum, maximum, and best guess values from each respondent. Results: The survey was completed by 15 experts. Interquartile ranges from pooled responses indicated that in the first year of a VLNC policy, smoking cessation could increase by 1.2-7.1 times the rate without the policy and switching to vaping by 1.3-8 times. Switching to illicitly supplied ‘normal’ nicotine cigarettes was estimated between 15-50% of those who smoke. Smoking initiation estimates varied greatly. Experts from Australia (n=8) consistently reported lower estimates for positive outcomes, and higher illicit market switching estimates, than experts from other countries. Conclusions: Given the absence of implementation evidence, this study provides Australia-specific estimates of the potential behavioural effects of a VLNC policy. The findings suggest that denicotinisation would accelerate declines in smoking, but that it may be undermined by illicit cigarette access in Australia. Estimates should be updated with real-world evidence as it becomes available. Implications: This study quantifies a range of behavioural responses to a national-level VLNC mandate in Australia, based on the knowledge of 15 global experts in tobacco control. The pooled responses indicate that a VLNC mandate could increase smoking cessation and switching to e-cigarette use, with variable impacts on youth smoking and vaping uptake. Denicotinisation could accelerate progress towards a tobacco endgame in Australia, but its benefits may be limited if illicit access to nicotine-containing cigarettes continues. Future modelling in Australia based on this analysis must explicitly consider the wide variation in expert responses, and other sources of evidence.
- Open Access
Modelling a tobacco-free generation policy in Australia: population health impacts under illicit market uncertainty
Objective: To estimate the potential health and equity impacts of a tobacco free generation (TFG) and T21 policy (increasing the legal age of sale to 21) in Australia, in the context of a complex market including widespread illicit tobacco and e-cigarette product availability. Design: A Markov macrosimulation model, parameterised with yearly net movements between legal smoking, illicit smoking, vaping, and dual use states, combined with a proportional multi-state lifetable. Setting: The Australian population, modelled as an open cohort for 40-years. Intervention: A ‘business-as-usual’ (BAU) scenario was compared to TFG and T21 policies, with both starting in 2026. Variations to policy impacts were tested under increasing background illicit market enforcement. Main outcome measures: The model estimates the health-adjusted life years (HALYs) and deaths over 40 years, under each scenario, with differences across age and socioeconomic status (SES) presented. Results: The TFG policy reduced daily smoking prevalence among 15-24-year-olds to 5.3% (95% uncertainty interval [UI] 4.8-6.0%) in 20 years’ time, compared to 7% under the T21 policy and 7.6% under BAU trends. Vaping was minimally impacted by either policy. The TFG policy resulted in 75,000 (95% UI 41,900-124,000) HALYs being gained over 40 years. The policy impact was larger when accompanied by increased illicit market enforcement, reducing daily smoking among 15-24-year-olds to 1·3% within 20 years. Both policies had greater prevalence and health impacts on more disadvantaged compared to advantaged SES groups. Conclusion: A TFG policy is expected to produce long-term benefits for the Australian population but would be most effective in combination with increased enforcement of illicit tobacco and e-cigarette markets. Novel strategies to increase quitting in addition to reducing uptake are needed to improve tobacco-related outcomes in the short to medium term. Plain language summary: The known: A ‘tobacco free generation (TFG)’ policy would theoretically minimise youth smoking uptake in Australia but may be undermined by rising illicit tobacco and e-cigarette use. The new: A TFG law in Australia may reduce daily smoking among 15-24-year-olds by 30% within 20 years, though resulting health impacts take longer to manifest. Larger impacts would also occur if smoking uptake via the illicit market was well controlled. The implications: A TFG policy could produce long-term benefits in Australia but should be implemented alongside policies to reduce illicit product supply and improve smoking cessation among adults who already smoke.
Open AccessModelling a tobacco-free generation policy in Australia: population health impacts under illicit market uncertainty
Objective: To estimate the potential health and equity impacts of a tobacco free generation (TFG) and T21 policy (increasing the legal age of sale to 21) in Australia, in the context of a complex market including widespread illicit tobacco and e-cigarette product availability. Design: A Markov macrosimulation model, parameterised with yearly net movements between legal smoking, illicit smoking, vaping, and dual use states, combined with a proportional multi-state lifetable. Setting: The Australian population, modelled as an open cohort for 40-years. Intervention: A ‘business-as-usual’ (BAU) scenario was compared to TFG and T21 policies, with both starting in 2026. Variations to policy impacts were tested under increasing background illicit market enforcement. Main outcome measures: The model estimates the health-adjusted life years (HALYs) and deaths over 40 years, under each scenario, with differences across age and socioeconomic status (SES) presented. Results: The TFG policy reduced daily smoking prevalence among 15-24-year-olds to 5.3% (95% uncertainty interval [UI] 4.8-6.0%) in 20 years’ time, compared to 7% under the T21 policy and 7.6% under BAU trends. Vaping was minimally impacted by either policy. The TFG policy resulted in 75,000 (95% UI 41,900-124,000) HALYs being gained over 40 years. The policy impact was larger when accompanied by increased illicit market enforcement, reducing daily smoking among 15-24-year-olds to 1·3% within 20 years. Both policies had greater prevalence and health impacts on more disadvantaged compared to advantaged SES groups. Conclusion: A TFG policy is expected to produce long-term benefits for the Australian population but would be most effective in combination with increased enforcement of illicit tobacco and e-cigarette markets. Novel strategies to increase quitting in addition to reducing uptake are needed to improve tobacco-related outcomes in the short to medium term. Plain language summary: The known: A ‘tobacco free generation (TFG)’ policy would theoretically minimise youth smoking uptake in Australia but may be undermined by rising illicit tobacco and e-cigarette use. The new: A TFG law in Australia may reduce daily smoking among 15-24-year-olds by 30% within 20 years, though resulting health impacts take longer to manifest. Larger impacts would also occur if smoking uptake via the illicit market was well controlled. The implications: A TFG policy could produce long-term benefits in Australia but should be implemented alongside policies to reduce illicit product supply and improve smoking cessation among adults who already smoke.
- Open Access
- 15 April 2026
- Published by Elsevier in SSRN Electronic Journal
Modelling the Impacts of Illicit Market Enforcement on Smoking Prevalence: Australian Case Study
Background: In Australia, daily smoking prevalence has fallen to below 10% (as of 2022-23) but 50-60% of the tobacco market is now illicit. Recent policy changes have restricted e-cigarette sales to pharmacy access only, yet illicit supply remains widespread. We aimed to estimate how different levels of enforcement against illicit tobacco and e-cigarette markets might affect future smoking, vaping, and mortality in Australia.Methods: We used the SHINE Tobacco simulation model that combines a Markov model of yearly smoking, vaping, and dual use transitions, with a proportional multi-state lifetable of tobacco-related diseases. We compare a ‘business-as-usual’ (BAU) scenario in which overall smoking declines, but use of illicitly traded tobacco and e-cigarettes remain widespread. The BAU scenario was compared to four hypothetical enforcement scenarios starting in 2025. Scenarios varied by enforcement intensity (maximum 90% reduction) and whether enforcement reduced all use of illicitly traded e-cigarettes or only naïve vaping, allowing for continued legal access for smoking cessation. Outcomes were daily smoking and vaping prevalence to 2044, and deaths averted over 20 years.Findings: Under BAU, daily smoking prevalence among people aged 15 years and older declined from 9·4% in 2024 to 5·7% in 2044, while vaping increased from 4·8% to 9·8%. High enforcement targeting both illicit tobacco and e-cigarette markets reduced smoking to 4·5% and vaping to 2·4% by 2044. The largest reduction in smoking occurred under high enforcement targeting the illicit tobacco market and naïve vaping only, with continued access to e-cigarettes for cessation, reducing smoking to 3% and averting 4,840 deaths over 20 years (95% uncertainty interval 4,050–5,800). While the model was moderately sensitive to changes in BAU transition rates, the ranking of enforcement scenarios remained the same across sensitivity analyses. Interpretation: Future smoking trajectories in Australia are likely to depend on both availability of products in the illicit market and the role of e-cigarettes in cessation. Stronger enforcement could accelerate smoking declines, but policy choices require balancing reductions in smoking, total nicotine use, and short-term health gains.
- 15 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessModelling the Impacts of Illicit Market Enforcement on Smoking Prevalence: Australian Case Study
Background: In Australia, daily smoking prevalence has fallen to below 10% (as of 2022-23) but 50-60% of the tobacco market is now illicit. Recent policy changes have restricted e-cigarette sales to pharmacy access only, yet illicit supply remains widespread. We aimed to estimate how different levels of enforcement against illicit tobacco and e-cigarette markets might affect future smoking, vaping, and mortality in Australia.Methods: We used the SHINE Tobacco simulation model that combines a Markov model of yearly smoking, vaping, and dual use transitions, with a proportional multi-state lifetable of tobacco-related diseases. We compare a ‘business-as-usual’ (BAU) scenario in which overall smoking declines, but use of illicitly traded tobacco and e-cigarettes remain widespread. The BAU scenario was compared to four hypothetical enforcement scenarios starting in 2025. Scenarios varied by enforcement intensity (maximum 90% reduction) and whether enforcement reduced all use of illicitly traded e-cigarettes or only naïve vaping, allowing for continued legal access for smoking cessation. Outcomes were daily smoking and vaping prevalence to 2044, and deaths averted over 20 years.Findings: Under BAU, daily smoking prevalence among people aged 15 years and older declined from 9·4% in 2024 to 5·7% in 2044, while vaping increased from 4·8% to 9·8%. High enforcement targeting both illicit tobacco and e-cigarette markets reduced smoking to 4·5% and vaping to 2·4% by 2044. The largest reduction in smoking occurred under high enforcement targeting the illicit tobacco market and naïve vaping only, with continued access to e-cigarettes for cessation, reducing smoking to 3% and averting 4,840 deaths over 20 years (95% uncertainty interval 4,050–5,800). While the model was moderately sensitive to changes in BAU transition rates, the ranking of enforcement scenarios remained the same across sensitivity analyses. Interpretation: Future smoking trajectories in Australia are likely to depend on both availability of products in the illicit market and the role of e-cigarettes in cessation. Stronger enforcement could accelerate smoking declines, but policy choices require balancing reductions in smoking, total nicotine use, and short-term health gains.
- Open Access
- 18 March 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 398, 119197
Estimating the harms from smoking and second-hand smoke exposure in social housing: a modelling study
- 18 March 2026
- Published by Elsevier in Social Science & Medicine
- Vol. 398, 119197
Open AccessEstimating the harms from smoking and second-hand smoke exposure in social housing: a modelling study
- Open Access
Specifying prospective compartmental models of chronic disease
Background Determining the impact of preventive interventions on future health and economic outcomes in a given population often requires parameterising disease models with forecast disease incidence, remission and case fatality rates. This paper outlines a method to specify these forecasts, using period estimates over several years from source data that are not necessarily coherent from a cohort perspective. Methods For a given chronic disease, the model is specified by first obtaining and smoothing source data inputs. We used Global Burden of Disease (GBD) period estimates of disease prevalence (p), incidence rates (i) and mortality rates (d) from 1990 to 2019 as a starting point, from which case fatality rates (f) were calculated. Values were smoothed by birth cohort within each calendar year using a quadratic Bezier curve, from which remission rates (r) were inferred. Next, each measure was projected for 20 years using log-linear regression by year, with 10-year age knots, produced independently by sex. Finally, a stochastic optimization algorithm was used to adjust i, f, and r to ensure longitudinal (cohort)-coherence such that they matched simulated forecasts of p and d, which were treated as the reference targets. Model output The method is illustrated by presenting model output for the 20 highest disability-adjusted life year-causing chronic diseases in Australia. Model fit was assessed visually, as well as through the relative and absolute differences between calibration output and targets (p and d). A subset model using GBD input data from 1990-2009 only was also produced and compared to 2019 GBD data to investigate the model's predictive validity. Conclusions Our method is a useful optimization procedure to derive cohort-coherent estimates of chronic disease in simulation models. For this analysis, readily available GBD period rates were used as input data; however, other raw data sources could also be applied for a given disease.
Open AccessSpecifying prospective compartmental models of chronic disease
Background Determining the impact of preventive interventions on future health and economic outcomes in a given population often requires parameterising disease models with forecast disease incidence, remission and case fatality rates. This paper outlines a method to specify these forecasts, using period estimates over several years from source data that are not necessarily coherent from a cohort perspective. Methods For a given chronic disease, the model is specified by first obtaining and smoothing source data inputs. We used Global Burden of Disease (GBD) period estimates of disease prevalence (p), incidence rates (i) and mortality rates (d) from 1990 to 2019 as a starting point, from which case fatality rates (f) were calculated. Values were smoothed by birth cohort within each calendar year using a quadratic Bezier curve, from which remission rates (r) were inferred. Next, each measure was projected for 20 years using log-linear regression by year, with 10-year age knots, produced independently by sex. Finally, a stochastic optimization algorithm was used to adjust i, f, and r to ensure longitudinal (cohort)-coherence such that they matched simulated forecasts of p and d, which were treated as the reference targets. Model output The method is illustrated by presenting model output for the 20 highest disability-adjusted life year-causing chronic diseases in Australia. Model fit was assessed visually, as well as through the relative and absolute differences between calibration output and targets (p and d). A subset model using GBD input data from 1990-2009 only was also produced and compared to 2019 GBD data to investigate the model's predictive validity. Conclusions Our method is a useful optimization procedure to derive cohort-coherent estimates of chronic disease in simulation models. For this analysis, readily available GBD period rates were used as input data; however, other raw data sources could also be applied for a given disease.
- Open Access
Estimating the harms from smoking and second-hand smoke exposure in social housing: a modelling study
Background: People living in social housing in Australia have higher prevalence of daily smoking and greater exposure to second-hand smoke (SHS), particularly in multi-unit housing where smoke can drift between dwellings. The health impact of this exposure has not been quantified for this population. Methods: We developed a Monte-Carlo matrix model of household SHS exposure, including smoke drift between dwellings in multi-unit housing, and linked it to the SHINE Tobacco simulation platform. The model projected health outcomes for the population living in social housing in the state of Victoria, Australia, over 20 years, comparing scenarios that eradicated SHS exposure and/or smoking with a business-as-usual (BAU) scenario of constant smoking prevalence. Outcomes were health-adjusted life years (HALYs) gained, and premature deaths averted across 31 smoking-attributable and eight SHS-attributable diseases. Findings: Eradicating SHS exposure within the social housing population of Victoria in 2025 could result in 5,350 HALYs (95% uncertainty interval [UI] 4,670-6,120) gained, and 600 premature deaths (95% UI 500-700) averted over 20 years. In multi-unit housing, about half of the SHS-related health gain was attributable to eliminating smoke drift between units. Overall, SHS eradication accounted for approximately 27% of the total health gain achievable if tobacco smoking were fully eradicated in this setting. Interpretation: Reducing SHS exposure in social housing would deliver substantial health benefits, with a large share resulting from preventing smoke drift in multi-unit housing. Better data on population dynamics and smoke infiltration would strengthen estimates and support policy design. Funding: This research was funded by a seed funding grant awarded by the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (NHMRC, GNT1198301)
Open AccessEstimating the harms from smoking and second-hand smoke exposure in social housing: a modelling study
Background: People living in social housing in Australia have higher prevalence of daily smoking and greater exposure to second-hand smoke (SHS), particularly in multi-unit housing where smoke can drift between dwellings. The health impact of this exposure has not been quantified for this population. Methods: We developed a Monte-Carlo matrix model of household SHS exposure, including smoke drift between dwellings in multi-unit housing, and linked it to the SHINE Tobacco simulation platform. The model projected health outcomes for the population living in social housing in the state of Victoria, Australia, over 20 years, comparing scenarios that eradicated SHS exposure and/or smoking with a business-as-usual (BAU) scenario of constant smoking prevalence. Outcomes were health-adjusted life years (HALYs) gained, and premature deaths averted across 31 smoking-attributable and eight SHS-attributable diseases. Findings: Eradicating SHS exposure within the social housing population of Victoria in 2025 could result in 5,350 HALYs (95% uncertainty interval [UI] 4,670-6,120) gained, and 600 premature deaths (95% UI 500-700) averted over 20 years. In multi-unit housing, about half of the SHS-related health gain was attributable to eliminating smoke drift between units. Overall, SHS eradication accounted for approximately 27% of the total health gain achievable if tobacco smoking were fully eradicated in this setting. Interpretation: Reducing SHS exposure in social housing would deliver substantial health benefits, with a large share resulting from preventing smoke drift in multi-unit housing. Better data on population dynamics and smoke infiltration would strengthen estimates and support policy design. Funding: This research was funded by a seed funding grant awarded by the NHMRC Centre of Research Excellence on Achieving the Tobacco Endgame (NHMRC, GNT1198301)
- 7 July 2025
- Published by BMJ in Tobacco Control
Modelling the potential impacts of limiting vaping product sales to pharmacies
Background Vaping rates are increasing globally. Restricting vaping products’ access may result in net population health loss if youths who vape switch to smoking, or net gain if it promotes cessation among people who smoke. We used simulation modelling to assess how two vaping restriction policies—over-the-counter (OTC) pharmacy access or prescription-only access via general practitioners—might impact vaping and smoking rates in Aotearoa New Zealand (A/NZ). Methods We adapted an established Markov model of smoking and vaping, linked to a proportional multistate lifetable, to simulate the A/NZ population from 2023 to 2044. Three business-as-usual (BAU) scenarios (‘low’, ‘medium’ and ‘high’ vaping) were informed by youth vaping trends. Intervention impacts were derived from prior research and expert elicitation. Results Compared with the medium BAU scenario with 50% vaping among 18–24-year olds by 2044, restricting to OTC pharmacy access reduced vaping prevalence by 6% and increased health-adjusted life years (HALYs). Only under the ‘high’ BAU scenario (60% vaping) did interventions marginally increase smoking (2% for OTC). Both interventions averted premature deaths and produced HALY gains. Interpretation Our model suggests modest reductions in vaping prevalence and net health gains from the OTC pharmacy policy, with minor benefits from a prescription-only approach. These findings underscore the importance of balancing the potential smoking cessation benefits of vaping with the need to curb youth uptake. Future research is required to better understand how vaping restriction policies could impact vaping and smoking dynamics in A/NZ, in particular, considering how illicit supply may impact policy effectiveness.
- 7 July 2025
- Published by BMJ in Tobacco Control
Modelling the potential impacts of limiting vaping product sales to pharmacies
Background Vaping rates are increasing globally. Restricting vaping products’ access may result in net population health loss if youths who vape switch to smoking, or net gain if it promotes cessation among people who smoke. We used simulation modelling to assess how two vaping restriction policies—over-the-counter (OTC) pharmacy access or prescription-only access via general practitioners—might impact vaping and smoking rates in Aotearoa New Zealand (A/NZ). Methods We adapted an established Markov model of smoking and vaping, linked to a proportional multistate lifetable, to simulate the A/NZ population from 2023 to 2044. Three business-as-usual (BAU) scenarios (‘low’, ‘medium’ and ‘high’ vaping) were informed by youth vaping trends. Intervention impacts were derived from prior research and expert elicitation. Results Compared with the medium BAU scenario with 50% vaping among 18–24-year olds by 2044, restricting to OTC pharmacy access reduced vaping prevalence by 6% and increased health-adjusted life years (HALYs). Only under the ‘high’ BAU scenario (60% vaping) did interventions marginally increase smoking (2% for OTC). Both interventions averted premature deaths and produced HALY gains. Interpretation Our model suggests modest reductions in vaping prevalence and net health gains from the OTC pharmacy policy, with minor benefits from a prescription-only approach. These findings underscore the importance of balancing the potential smoking cessation benefits of vaping with the need to curb youth uptake. Future research is required to better understand how vaping restriction policies could impact vaping and smoking dynamics in A/NZ, in particular, considering how illicit supply may impact policy effectiveness.
- Open Access
- 16 February 2025
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 54 (2)
A novel tobacco forecasting model by multiple sociodemographic strata in Australia
Background: Australia is one of several countries aiming to achieve a commercial tobacco endgame, with a current target of ≤5% daily smoking prevalence by 2030. Like other jurisdictions, the Australian target ignores large variations in smoking across sociodemographic groups and risks perpetuating current smoking-related inequities. To help mitigate this risk, we calculated future smoking rates under business-as-usual for multiple sociodemographic categories and compared them to the endgame target. Methods: We used a simulated annealing optimization approach to estimate historic daily smoking rates in Australia by six dimensions of sex, age, remoteness, index of relative socioeconomic advantage and disadvantage, and Indigenous status, using multiple datasets from 2001 to 2022–23. We applied logistic regression to the modelled outputs to forecast cohort smoking rates for 30 years. Results: At the population level, daily smoking is expected to reach 7.8% by 2030 under business-as-usual. Of the 15 strata combinations of remoteness and socioeconomic status in the model, only two met the ≤5% target by 2030, with smoking prevalence remaining highest (34.6% in 2030) for people living in the most disadvantaged (remote, SES1) areas. Conclusions: Our modelling suggests that if equity is not at the forefront of Australian tobacco policy, ongoing smoking disparities are likely to continue even if the endgame goal is achieved. Our approach offers a crucial baseline for assessing the impact of tobacco control interventions by different sociodemographic dimensions and presents a methodological framework that could be adapted for analysing smoking-related inequities in other jurisdictions. This framework should also be extended, incorporating uncertainty into modelled estimates.
- 16 February 2025
- Published by Oxford University Press (OUP) in International Journal of Epidemiology
- Vol. 54 (2)
Open AccessA novel tobacco forecasting model by multiple sociodemographic strata in Australia
Background: Australia is one of several countries aiming to achieve a commercial tobacco endgame, with a current target of ≤5% daily smoking prevalence by 2030. Like other jurisdictions, the Australian target ignores large variations in smoking across sociodemographic groups and risks perpetuating current smoking-related inequities. To help mitigate this risk, we calculated future smoking rates under business-as-usual for multiple sociodemographic categories and compared them to the endgame target. Methods: We used a simulated annealing optimization approach to estimate historic daily smoking rates in Australia by six dimensions of sex, age, remoteness, index of relative socioeconomic advantage and disadvantage, and Indigenous status, using multiple datasets from 2001 to 2022–23. We applied logistic regression to the modelled outputs to forecast cohort smoking rates for 30 years. Results: At the population level, daily smoking is expected to reach 7.8% by 2030 under business-as-usual. Of the 15 strata combinations of remoteness and socioeconomic status in the model, only two met the ≤5% target by 2030, with smoking prevalence remaining highest (34.6% in 2030) for people living in the most disadvantaged (remote, SES1) areas. Conclusions: Our modelling suggests that if equity is not at the forefront of Australian tobacco policy, ongoing smoking disparities are likely to continue even if the endgame goal is achieved. Our approach offers a crucial baseline for assessing the impact of tobacco control interventions by different sociodemographic dimensions and presents a methodological framework that could be adapted for analysing smoking-related inequities in other jurisdictions. This framework should also be extended, incorporating uncertainty into modelled estimates.
- Open Access
- 26 December 2023
- Published by Wiley in Medical Journal of Australia
- Vol. 220 (4) , 180-183
The Australian Government's new vaping policy should be part of a larger plan towards a tobacco endgame
- 26 December 2023
- Published by Wiley in Medical Journal of Australia
- Vol. 220 (4) , 180-183
Open AccessThe Australian Government's new vaping policy should be part of a larger plan towards a tobacco endgame